BioSpace News Archive

CNS Pharmaceuticals, Inc. today announced that it is aware that the Federal Deposit Insurance Corp. has taken control of Silicon Valley due to liquidity concerns.

Can-Fite BioPharma Ltd. announced today that patients with decompensated cirrhosis, an advanced form of cirrhosis associated with liver failure for which there are no therapeutic options other than liver transplantation, will be treated with Namodenoson at the Soroka Medical Center in Israel under compassionate use.

Kezar Life Sciences, Inc. today announced that the Company will pull forward its virtual Research and Development Day to Wednesday, March 15, 2023 at 4:30 pm ET/1:30 pm PT.

Abivax SA is aware that Silicon Valley Bank was closed on March 10, 2023, by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation as receiver.

Mersana Therapeutics, Inc. today announced that the Phase 1 trial of XMT-2056 has been placed on clinical hold by the U.S. Food and Drug Administration (FDA).

Thorne HealthTech, Inc. today announced that it has appointed Saloni Varma as Chief Financial Officer (CFO).

DexCom, Inc. (NASDAQ: DXCM), today issued the following statement in response to speculation following the developments at Silicon Valley Bank, including a recent CNBC article.

Susan D. Klugman, MD, FACOG, FACMG is the new president of the American College of Medical Genetics and Genomics, the national professional organization for clinical and laboratory genetics professionals.

Corium, LLC announces the upcoming presentation of positive data about its first-in-class attention-deficit hyperactivity disorder medicine AZSTARYS at two national medical association meetings this month.

InMode Ltd., a leading global provider of innovative medical technologies, announced that that it does not hold cash deposits or securities at Silicon Valley Bank.